Search for drugs:

CARIPRAZINE


DIR Classification


Classification:Ambiguous
Severity Score:1.0

Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF

  • CLINICAL PHARMACOLOGY
  • Pharmacodynamics
  • Effect on QTc Interval
  • At a dose three-times the maximum recommended dose, cariprazine does not prolong the QTc interval to clinically relevant extent.

Postmarketing Surveillance

Contingency Table:

Current Drug
Other Drugs
QT Prolongation
5
24087
Other ADRs
4805
38376782

Odds Ratio = 1.658

Drug Property Information



ATC Code(s):
  • N05AX15 - cariprazine
    • N05AX - Other antipsychotics
    • N05A - ANTIPSYCHOTICS
    • N05 - PSYCHOLEPTICS
    • N - NERVOUS SYSTEM
Active Ingredient:CARIPRAZINE
Active Ingredient UNII:F6RJL8B278
Drugbank ID:DB06016
PubChem Compound:11154555
CTD ID:C533287
PharmGKB:
CAS Number:839712-12-8
Dosage Form(s):capsule, gelatin coated; kit
Route(s) Of Administrator:oral
Daily Dose:
  • 3.0 mg/day N05AX15
Chemical Structure:
SMILE Code:
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1

Reference

1: Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.

[Barabássy Ágota,Sebe Barbara,Acsai Károly,Laszlovszky István,Szatmári Balázs,Earley Willie R,Németh György]
Neuropsychiatr Dis Treat,2021 Apr 7;17:957-970. PMID: 33854317

2: [Brexpiprazole for treatment of schizophrenia: a critical literature study].

[Spoelstra S K,Baas C A J,Knegtering H]
Tijdschr Psychiatr,2021;63(1):48-55. PMID: 33537974

3: Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.

[Smith Robert C,Leucht Stefan,Davis John M]
Psychopharmacology (Berl),2019 Feb;236(2):545-559. PMID: 30506237

4: Clinical potential of cariprazine in the treatment of acute mania.

[Altınbaş Kürşat,Guloksuz Sinan,Oral Esat Timuçin]
Psychiatr Danub,2013 Sep;25(3):207-13. PMID: 24048386

5: A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia.

[Caccia Silvio,Invernizzi Roberto William,Nobili Alessandro,Pasina Luca]
Ther Clin Risk Manag,2013;9:319-28. PMID: 23966785

Disclaimer:

The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.

Any mention of commercial products is for clarification and not intended as endorsement.